Aarti Pharmalabs Ltd Financials
Company Logo

Aarti Pharmalabs Ltd Financial Statement

Aarti Pharmalabs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue527.12
Operating Expense386.50
Net Profit88.85
Net Profit Margin16.86
Earning Per Share9.80
EBIDTA130.81
Effective Tax Rate10.55

Aarti Pharmalabs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,502.13
Operating Expenses Annual1,155.97
Operating Profit Annual357.17
Interest Annual16.63
Depreciation64.74
Net Profit Annual200.65
Tax Annual73.87

Aarti Pharmalabs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.30
Cash Flow from Operations183.69
Cash Flow from Investing-184.40
Cash Flow from Financing4.40
Cash Flow at the End4

Aarti Pharmalabs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)23.78
PBIT Margin (%)19.38
PBT Margin (%)18.21
Net PROFIT Margin (%)13.36
Return On Networth / Equity (%)13.11
Return On Networth /Employed (%)16.40
Return On Assets (%)11.35
Total Debt / Equity (X)0.16
Asset Turnover Ratio (%)0.85

Aarti Pharmalabs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1,011.75
Total Current Assets Annual1,134.06
Non Current Assets Annual1,162.85
Total Shareholders Funds Annual1,621.46
Total Assets Annual2,296.91

Aarti Pharmalabs Ltd Earning Calls

EPS (INR)

Expected

9.75

Reported

9.75

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by 0.00%

FAQS on Aarti Pharmalabs Ltd Financials

As of May 16, 2025, Aarti Pharmalabs Ltd has a market capitalization of 6,784.45 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Aarti Pharmalabs Ltd is with a debt-to-equity ratio of 0.22.

In FY 2024 , Aarti Pharmalabs Ltd recorded a total revenue of approximately 1,771.35 Cr marking a significant milestone in the company's financial performance.

Aarti Pharmalabs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..

Aarti Pharmalabs Ltd's current PE ratio is 26.36.

Aarti Pharmalabs Ltd's ROCE averaged 15.6% from the FY ending March 2023 to 2025, with a median of 15.4%. It peaked at 15.9% in March 2025, reflecting strong capital efficiency over the period..

Aarti Pharmalabs Ltd's latest EBIT is Rs. 361.97 Cr, surpassing the average EBIT of Rs. 302.32 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions